"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(sack-KWIN-uh-vihr MEH-sih-LATE)
Fortovase, Invirase
Class: Antiviral

 Action Inhibits human immunodeficiency virus (HIV) protease, the enzyme required to form functional proteins in HIV-infected cells.

 Indications Treatment of advanced HIV infection. Saquinavir is given in combination with nucleoside analogs (eg, zidovudine).

 Contraindications Coadministration with cisapride, ergot derivatives, midazolam, triazolam.

 Route/Dosage

ADULTS & CHILDREN ³ 16 YR: PO Three 200 mg capsules (600 mg) tid within 2 hrs after a full meal.

 Interactions

Carbamazepine, dexamethasone, nevirapine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, St. John’s wort, other cytochrome P450 3A4 inducers: May increase metabolism of saquinavir and decrease serum levels. Clarithromycin, delavirdine, indinavir, ketoconazole, nelfinavir, ritonavir: May decrease metabolism of saquinavir and increase serum levels. Cisapride, cyclosporine, ergot derivatives, fentanyl, midazolam, triazolam, other drugs metabolized by cytochrome P450 3A4: Serum levels of these drugs may be elevated, increasing the risk of toxicity. Clarithromycin, nelfinavir, sildenafil: Saquinavir may increase levels of these drugs. Aldesleukin, cyclosporine, grapefruit juice: May increase saquinavir serum levels. Warfarin: The anticoagulant effect may be decreased.

 Lab Test Interferences None well documented.

 Adverse Reactions

CNS: Paresthesia; numbness; confusion; seizures; headache; depression; insomnia; anxiety; libido disorder. DERM: Rash; photosensitivity; eczema; verruca; Stevens-Johnson syndrome; bullous skin eruption. EENT: Taste alteration. GI: Diarrhea; abdominal pain and discomfort; nausea; dyspepsia; flatulence; vomiting; constipation; intestinal obstruction. GU: Nephrolithiasis; acute renal insufficiency. HEMA: Acute myeloblastic leukemia; hemolytic anemia; thrombocytopenia. HEPA: Elevated liver function tests; jaundice; portal hypertension. OTHER: Ataxia; fatigue; pain weakness; ascites; pancreatitis; drug fever; intracranial hemorrhage.

 Precautions

Pregnancy: Category B. Lactation: Undetermined. HIV-infected mothers should not breastfeed their infants. Children: Not recommended for children < 16 yr. Clinical chemistry: Perform clinical chemistry tests prior to and at appropriate intervals during therapy. Dosage adjustment: Do not reduce dose; lower doses do not exhibit antiviral activity. Hepatic function impairment: Exercise caution when administering to patients with hepatic insufficiency (liver function tests > 5 times upper limit of normal). Nucleoside analog therapy: Saquinavir must be used in combination with nucleoside analog (eg, AZT [zidovudine], ddC [zalcitabine]) therapy. Photosensitivity: May occur; take protective measures against exposure to ultraviolet light or sunlight until tolerance is determined.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • The medication should be taken within 2 hr after a full meal.
  • Doses < 600 mg tid are not effective.
  • Store capsules at room temperature in a tightly closed bottle.
  • Store Invirase capsules at room temperature in a tightly closed bottle.
  • Store Fortovase capsules in the refrigerator 2° to 8°C (36° to 46°F).

 Assessment/Interventions

  • Obtain patient history.
  • Assess for history of impaired hepatic function.
  • Obtain baseline triglycerides, SGOT, SGPT, GGT, CPK, and uric acid. Monitor periodically during treatment.
  • Monitor WBC and differential. Note any significant changes.
  • Monitor Hct and Hgb frequently (severe anemia may require blood transfusions).
OVERDOSAGE: SIGNS & SYMPTOMS
  No acute toxicities or sequelae have been reported

 Patient/Family Education

  • Advise patient to take the medication exactly as prescribed.
  • Advise patient regarding importance of taking after a meal.
  • Warn patient not to alter the dose or discontinue the medication without consulting the health care provider.
  • Instruct patient not to take any other medications, including otc medications, without consulting a healthcare provider.
  • Explain that a patient will be required to have frequent follow-up blood and urine tests during the course of the treatment and to keep appointments.
  • Inform patient that this medication is NOT a cure for HIV infection and secondary illnesses associated with the disease may continue to be acquired.
  • Emphasize to patient, family, and significant others that this medication does NOT reduce the risk of transmitting HIV to others through sexual contact or blood contamination.
  • Inform patient to report any serious side effects to a health care provider.
  • Explain that the long-term effects of this medication are not known, and the initial results have not demonstrated a reduction in symptoms or prolongation of life.
  • Caution patient regarding possibility of photosensitivity and to use protective measures until tolerance is determined.
  • Advise patient that saquinavir is recommended for use in combination with active antiretroviral therapy and adherence to the prescribed regimen is strongly recommended.
  • Advise patient to store Fortovase capsules in the refrigerator 2° to 8°C (36° to 46°F) until the expiration date; once brought to room temperature, use capsules within 3 months.
  • Inform patient that redistribution or accumulation of body fat may occur and that long-term health effects are not known.


Popularity: 1% [?]


If you're still unable to find appropriate information in the article, please use search form below